Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.0950
-0.0100 (-9.52%)
May 20, 2026, 5:21 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 12.96 million as of May 21, 2026. Its market cap has decreased by -44.41% in one year.
Market Cap
12.96M
Enterprise Value
18.62M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 12.96M, a decrease of -79.67%. That is a compound annual growth rate of -19.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 12.96M | -26.57% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Resverlogix | 30.08M |
| BriaCell Therapeutics | 29.94M |
| Thiogenesis Therapeutics | 29.55M |
| Pharmala Biotech Holdings | 16.33M |
| Britannia Life Sciences | 13.79M |
| PreveCeutical Medical | 11.96M |
| Hemostemix | 11.87M |
| Glow Lifetech | 10.58M |